Culture Conditions for Human Induced Pluripotent Stem Cell-Derived Schwann Cells: A Two-Centre Study.
Zhong HuangRebecca PowellSvenja KankowskiJames B PhillipsKirsten Haastert-TaliniPublished in: International journal of molecular sciences (2023)
Adult human Schwann cells represent a relevant tool for studying peripheral neuropathies and developing regenerative therapies to treat nerve damage. Primary adult human Schwann cells are, however, difficult to obtain and challenging to propagate in culture. One potential solution is to generate Schwann cells from human induced pluripotent stem cells (hiPSCs). Previously published protocols, however, in our hands did not deliver sufficient viable cell numbers of hiPSC-derived Schwann cells (hiPSC-SCs). We present here, two modified protocols from two collaborating laboratories that overcome these challenges. With this, we also identified the relevant parameters to be specifically considered in any proposed differentiation protocol. Furthermore, we are, to our knowledge, the first to directly compare hiPSC-SCs to primary adult human Schwann cells using immunocytochemistry and RT-qPCR. We conclude the type of coating to be important during the differentiation process from Schwann cell precursor cells or immature Schwann cells to definitive Schwann cells, as well as the amounts of glucose in the specific differentiation medium to be crucial for increasing its efficiency and the final yield of viable hiPSC-SCs. Our hiPSC-SCs further displayed high similarity to primary adult human Schwann cells.
Keyphrases
- induced apoptosis
- cell cycle arrest
- endothelial cells
- induced pluripotent stem cells
- peripheral nerve
- healthcare
- signaling pathway
- stem cells
- type diabetes
- squamous cell carcinoma
- adipose tissue
- risk assessment
- young adults
- climate change
- mesenchymal stem cells
- single cell
- blood pressure
- pluripotent stem cells
- metabolic syndrome